entertainment -WSS

entertainment

author：hotspot 2025-09-29 23:04:46 - browse：1932

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Where does female orgasm come from? Scientists think they know

WSS

States increasingly look to regulate hospital facility fees

Norman Reedus' Daryl Dixon

How a key Senate committee is planning to regulate PBMs

India sets sights on home

Lindsay Lohan welcomes 1st child with husband Bader Shammas

Lindsay Lohan welcomes 1st child with husband Bader Shammas

explore

entertainment

leisure time

Virginia high school admissions case could be legal follow

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

DIEP, the 'gold standard' of breast reconstruction, is under threat

Where does female orgasm come from? Scientists think they know

Activists slam private health insurers over coverage restrictions

Burning questions about Delta and the next phase of the Covid pandemic

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How dance can help health care workers heal from trauma

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The kidney, in all its complexity, is captured in a new atlas

knowledge

New requirements coming in 2024 for Americans traveling to Europe

Men with early prostate cancer can safely opt out of treatment

New requirements coming in 2024 for Americans traveling to Europe

India sets sights on home

Celebrate National Dole Whip Day for 3 days this week at Disney

Medical experts are missing from AI regulatory conversations

knowledge

explore

leisure time

leisure time